{
    "Trade/Device Name(s)": [
        "N Antisera to Human Transferrin",
        "N Antisera to Human Transferrin Assay"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K053075",
    "Predicate Device Reference 510(k) Number(s)": [
        "K972840"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DDG"
    ],
    "Summary Letter Date": "March 16, 2006",
    "Summary Letter Received Date": "November 1, 2005",
    "Submission Date": "October 28, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.5880"
    ],
    "Regulation Name(s)": [
        "Transferrin immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Transferrin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma",
        "EDTA plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BN Tm Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Immunonephelometry"
    ],
    "Methodologies": [
        "Immunochemical reaction",
        "Nephelometric measurement"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for N Antisera to Human Transferrin immunonephelometric assay for quantitative determination of transferrin using BN Tm Systems",
    "Indications for Use Summary": "In vitro diagnostic reagents for quantitative determination of transferrin in serum, heparinized and EDTA plasma, and urine to aid in diagnosing malnutrition, inflammation, infection, and iron deficiency anemia",
    "fda_folder": "Immunology"
}